Jens Wagner

Title: Jens Wagner: Innovator in Neurodegenerative Disease Research

Introduction

Jens Wagner is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 2 patents, Wagner's work focuses on developing drugs that inhibit the aggregation of proteins associated with various diseases.

Latest Patents

Wagner's latest patents include a groundbreaking drug designed to inhibit the aggregation of proteins involved in diseases linked to protein aggregation and neurodegenerative conditions. The invention relates to a compound represented by formula (E), which is intended for use in the treatment or prevention of these diseases. Additionally, the patent covers pharmaceutical and diagnostic compositions that incorporate this compound, as well as a method for imaging deposits of aggregated proteins. A kit for preparing a detectably labeled compound is also disclosed in the patent.

Career Highlights

Throughout his career, Jens Wagner has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and Ludwig Maximilian University of Munich. His research has been pivotal in advancing our understanding of protein aggregation and its implications for neurodegenerative diseases.

Collaborations

Wagner has collaborated with notable colleagues, including Armin Giese and Uwe Bertsch, to further his research and innovations in the field.

Conclusion

Jens Wagner's contributions to the field of neurodegenerative diseases through his patents and research collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in treatment and prevention strategies for these challenging conditions.